{ "@context": "https://frontierpicks.com/schemas/dossier.v1.json", "ticker": "CMCO", "name": "Columbus McKinnon Corporation", "url": "https://frontierpicks.com/dossiers/CMCO/", "json_url": "https://frontierpicks.com/dossiers/CMCO.json", "status": "DORMANT", "current_conviction": "MEDIUM", "graded_conviction": "MEDIUM", "archetype": { "code": "a4", "n": 4 }, "current_thesis": "First full combined quarter post-Kito Crosby beat hard (adj EPS $0.61 vs $0.27 est) and drove a guidance raise on all three lines on 2026-07-30; the leg being bought is deleveraging from 4.9x toward sub-4x by FY28 on $70M of synergies. No company catalyst until the ~late-Oct Q2 print, with price 12.1% off the $23.01 high.", "invalidation_trigger": "A daily close below $18.50 hands back the 2026-07-30 guidance-raise shelf; secondary break is a Q2 FY27 print (~2026-10-29, est.) showing Credit Agreement Net Leverage above 4.9x, book-to-bill under 1.0x, or a cut to the $2.09–2.15B FY27 sales guide.", "catalyst_date": null, "outcome": "INVALIDATED", "outcome_date": "2026-08-18", "invalidation_fired": true, "themes": [ "cyclical-industrials", "critical-materials-rare-earths" ], "tags": [], "sources": [], "notes": [ "Fiscal year ends March 31: \"Q1 FY27\" is the quarter ended 2026-06-30 and \"FY27\" the year ending 2027-03-31.", "Purchase accounting from the 2026-02-03 Kito Crosby close keeps GAAP and adjusted results far apart; FY27 amortization is guided at $135-140M.", "CD&R holds $800M of Series A cumulative convertible participating preferred (7.0% dividend, $37.68 conversion) plus three of twelve board seats.", "The FTC-required divestiture of U.S. power chain hoist and chain manufacturing closed 2026-03-04, distorting YoY revenue comparisons through FY27.", "Capital structure since February 2026: $1.65B floating-rate Term Loan B, $900M 7.125% senior secured notes due 2033, $500M revolver.", "Sell-side coverage is four analysts deep with targets spanning $18 to $30; single-firm revisions move the consensus materially." ], "body_markdown": "## Current Thesis\n\nThe leg on offer is unchanged in substance and worse in structure. What an investor buys here is deleveraging arithmetic: Credit Agreement Net Leverage of 4.9x at 2026-06-30 against a stated path below 4x by FY28, funded by $70M of targeted annual run-rate synergies from the $2.7B Kito Crosby acquisition that closed 2026-02-03. The 2026-07-30 print delivered on that frame — adjusted EPS $0.61 versus $0.27 consensus, sales $531.461M versus $501.262M consensus, guidance raised on all three lines — and the equity has since handed the move back. The 2026-08-21 close of $17.62 sits below the $20.22 close of 2026-08-07 and 23.4% under the $23.01 52-week high, with RSI(14) at 32.1, and it does so without a company headline since the 2026-08-05 rating maintenances. The shelf built by the July print is gone; the fundamental case now has to survive ten weeks of no company news before the Q2 FY27 print marks it.\n\n## Bull Case\n\n- **The first full combined quarter cleared consensus by a wide margin.** Adjusted EPS $0.61 against $0.27 estimated; net sales $531.461M against $501.262M estimated (2026-07-30 release, quarter ended 2026-06-30).\n- **Order intake exceeded shipments.** Orders $568.1M versus sales $531.5M gives a 1.1x book-to-bill for the June quarter; legacy Columbus McKinnon net sales grew 12.7% YoY on U.S. short-cycle demand per CEO David Wilson.\n- **Margin expanded on mix, synergies and input costs simultaneously.** Adjusted gross margin 38.1% (+380bps YoY), adjusted EBITDA $111.5M at a 21.0% margin (+720bps YoY), per the 2026-07-30 release.\n- **All three FY27 guidance lines were raised in one release**: sales to $2.09–2.15B from $2.05–2.12B, adjusted EBITDA to $405–420M from $390–410M, adjusted EPS to $1.90–2.10 from $1.70–1.90 against a $1.75 consensus. The EPS guide rests on published assumptions — 52M adjusted diluted shares, $135–140M amortization, $75–80M depreciation, 25% normalized tax — each checkable at the next print.\n- **Synergy capture is early-stage.** Management signalled confidence in exceeding the original $70M annual run-rate target with Q1 realization weighted to SG&A, leaving the manufacturing and procurement tranches ahead.\n- **Price now sits below every published target.** The four-analyst consensus stands at $26 with a $18–$30 range; the last two actions, both dated 2026-08-05, were maintenances — J.P. Morgan (James Kirby) Buy at $29 and D.A. Davidson (Matt Summerville) Hold at $18. The 2026-08-21 close of $17.62 is under the low end of that band.\n\n## Bear Case\n\n- **The August decline arrived without a headline.** No company disclosure sits between the 2026-08-05 rating maintenances and the 2026-08-21 close of $17.62, and the 2026-08-14 annual meeting produced nothing that moved the name. Supply met a thin bid in a company whose common market capitalisation was $502.88M at that close.\n- **GAAP and adjusted results describe different companies.** The June quarter produced a GAAP net loss of $88.7M, or −$2.05 per diluted share, against $30.5M of adjusted net income, with $135–140M of FY27 amortization guided. Screens built on reported earnings keep excluding the name.\n- **The fixed charge does not flex with demand.** The FY27 interest assumption of $185–190M sits against a $405–420M adjusted EBITDA guide, on $1.65B of floating-rate Term Loan B, $900M of 7.125% senior secured notes due 2033 and a $500M revolver.\n- **Cash conversion has not shown up yet.** Q1 operating cash flow $25.6M and free cash flow $20.0M ($32.4M excluding deal costs) against $111.5M of adjusted EBITDA. Total liquidity was $567.1M at 2026-06-30.\n- **The preferred ranks ahead of the common.** CD&R holds $800M of Series A cumulative convertible participating preferred at a 7.0% dividend and a $37.68 conversion price, plus three of twelve board seats. The FY27 guide assumes 52M adjusted diluted shares against a common market capitalisation of $502.88M.\n- **Coverage is four analysts deep and dispersed $18 to $30.** A name this thinly followed reprices on flow rather than on new information between quarters.\n\n## Setup & Price Structure\n\n- Reference close 2026-08-21: **$17.62**. Distance from the $23.01 52-week high: **−23.4%**. Three-month price change: **+18.3%**. RSI(14): **32.1**.\n- The $18.50 area established by the 2026-07-30 guidance raise has been lost. The prior published break condition on this name was framed there and it has been taken out on a closing series, so the structure question is now whether the pre-print zone holds rather than whether the breakout extends.\n- **The narrative is maturing.** The dating: the last fresh piece of news flow was J.P. Morgan's 2026-07-31 target raise to $29; the 2026-08-05 actions from both covering firms were maintenances rather than initiations or revisions; the 2026-08-14 annual meeting came and went; and the calendar holds no company event before the Q2 FY27 print in late October. The acquisition-and-deleveraging story is fully disclosed and now gets marked four times a year. Should the pre-print zone fail alongside a Q2 print that shows leverage rising, the correct label becomes dead, and this note would say so.\n- **Crowding and positioning observables**, stated as observables: coverage is four analysts with a $26 consensus; the 2026-08-21 close is beneath the lowest published target of $18; RSI(14) at 32.1 is at the low end of its band rather than extended above a rising average; there is no earnings date inside 30 days, so no imminent event is compressing the flow; the quarterly dividend of $0.07 went ex on 2026-08-07 and paid 2026-08-17, removing that date from the near calendar. Nothing in the visible record shows the retail-sentiment clustering or issuance-into-strength pattern that marks a crowded long.\n\n## Catalyst Calendar (next 30 days)\n\n- **~2026-09-01** — ISM Manufacturing PMI for August (first-business-day release). Legacy Columbus McKinnon's 12.7% growth was tied to U.S. short-cycle demand; the new-orders sub-index is the public proxy for whether the 1.1x book-to-bill held through the September quarter.\n- **~2026-09-16 (est.)** — September FOMC decision. $1.65B of Term Loan B is floating-rate, so the path of short rates feeds the $185–190M FY27 interest assumption directly.\n- **No company-scheduled event falls inside the window.** The next company mark is the Q2 FY27 print, estimated ~2026-10-29, which should also carry the next dividend declaration.\n\n## What Would Change Our Mind\n\nThe structure that framed the prior read — the shelf the 2026-07-30 guidance raise built around $18.50 — has already failed on a closing series, and the 2026-08-14 annual meeting passed without producing a replacement catalyst. What remains gradeable from here: a weekly close below $16.50 would mark the post-print advance as fully unwound and put the shares more than 8% under the lowest published sell-side target of $18 (D.A. Davidson, 2026-08-05), at which point the equity is being priced as a levered stub rather than as a deleveraging story. On the fundamental side, the Q2 FY27 print (~2026-10-29, est.) showing Credit Agreement Net Leverage above the 4.9x posted at 2026-06-30, book-to-bill under 1.0x, or any reduction to the $2.09–2.15B FY27 sales guide or the $70M synergy target, would break the case independent of price. Management pushing the sub-4x leverage goal beyond FY28 does the same.\n\nWorking the other way: a Q2 print with leverage inside 4.9x, free cash flow converting toward the $111.5M quarterly adjusted EBITDA run-rate, and book-to-bill at or above 1.0x would restore the leg — that combination is what the late-October date exists to resolve.\n\n## Correlation Notes\n\n- The equity behaves as a residual claim on EBITDA rather than as a typical mid-cap industrial: a $502.88M common market capitalisation at the 2026-08-21 close sits behind $2.55B of funded debt and $800M of preferred. Small changes in the EBITDA outlook translate into outsized equity moves in both directions.\n- Sensitivity runs through U.S. short-cycle industrial demand — ISM new orders, lifting and rigging exposure to construction, energy and mining capex — and through high-yield credit conditions, since the deleveraging path assumes ordinary access to refinancing on the 2033 notes and the Term Loan B.\n- Rate-path sensitivity is direct and mechanical via the floating-rate Term Loan B, which is unusual for an industrial of this size and decouples the name from unlevered peers on hawkish repricing.\n- The FTC-required divestiture of U.S. power chain hoist and chain manufacturing closed 2026-03-04 and distorts YoY revenue comparisons through FY27, so screen-driven flow keyed to reported growth rates reads this name incorrectly for another three quarters.", "first_seen": "2026-07-31", "last_analyzed": "2026-08-22T07:35:58+00:00", "last_synthesized": "2026-08-22", "last_update_source": "watchlist_research", "license": "Content © FrontierPicks. Cite the canonical URL." }